6.5 C
New York
Sunday, February 28, 2021

Newbie Venom developer promotes a cure for COVID-19

Must Read

COVID tests drop, but the US may be exposed

Demand for coronavirus screening is plummeting in U.S. communities. The decline comes at an important time in the pandemic:...

UK pays one final tribute to its hero, “Captain Tom”

The United Kingdom paid a final tribute this Saturday to its hero "Captain Tom", a veteran famous for having...

The world’s largest investment fund warns of a new bubble

The market for socially responsible investments may face a collapse soon, although it has great long-term potential, believes Nicolai...
Manish Saini
Manish works as a Journalist and writer at Revyuh.com. He has studied Political Science and graduated from Delhi University. He is a Political engineer, fascinated by politics, and traditional businesses. He is also attached to many NGO's in the country and helping poor children to get the basic education. Email: Manish (at) revyuh (dot) com

The new drug, according to the scientist, fights against the virus and restores body cells.

One of the developers of the Novichok agent(a group of nerve agents, some of which are binary chemical weapons), Leonid Rink is planing to launch a drug named Immofon, capable of neutralizing the cytokine storm that has caused numerous deaths in COVID-19 patients

“It works against viral diseases and regenerates cells after the reaction of the immune system, that is, it eliminates the cytokine storm that, in the opinion of many experts, is one of the causes of mortality from COVID-19,” Rink explained.

The new drug, according to the chemist, is based on an antileprosy synthesized in the Soviet Union in 1967, Diucifon, but it dissolves well in water and plasma unlike the prototype. 

It combines dapsone with two methyluracil molecules that enhance metabolism in tissues and stimulate the regeneration process.

In addition to COVID-19, the drug could be used in the treatment of lupus erythematosus, scleroderma, rheumatoid arthritis, psoriasis, allergies, leukemias, and lung diseases.

The scientist noted that the drug was tested on 700 elderly volunteers.

“There was not a single severe stage and not a single death after infection,” Rink said, speaking of the results of drug testing.

- Advertisement -
- Advertisement -

Latest News

COVID tests drop, but the US may be exposed

Demand for coronavirus screening is plummeting in U.S. communities. The decline comes at an important time in the pandemic:...
- Advertisement -

More Articles Like This

- Advertisement -